New York S 4640: Relates to onsite overdose response services and requires certain locations and venues to maintain a supply of opioid antagonists

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S04640 Summary:

BILL NOS04640A

&nbsp

SAME ASNo Same As

&nbsp

SPONSORFERNANDEZ

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §§3309, 3309-b & 3000-a, Pub Health L

&nbsp

Authorizes the commissioner of health to establish standards for approval of onsite overdose response services; requires nightlife establishments, sporting or event centers, theaters, concert venues, and amusement parks to maintain a supply of opioid antagonists; provides that emergency use of opioid antagonist is covered by good Samaritan law.

Go to top S04640 Actions:

BILL NOS04640A

&nbsp

02/10/2025REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

05/06/2025AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

05/06/2025PRINT NUMBER 4640A

05/22/20251ST REPORT CAL.1279

05/27/20252ND REPORT CAL.

05/28/2025ADVANCED TO THIRD READING 

06/11/2025PASSED SENATE

06/11/2025DELIVERED TO ASSEMBLY

06/11/2025referred to health

01/07/2026died in assembly

01/07/2026returned to senate

01/07/2026REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

05/21/20261ST REPORT CAL.1318

05/26/20262ND REPORT CAL.

05/27/2026ADVANCED TO THIRD READING 

06/01/2026PASSED SENATE

06/01/2026DELIVERED TO ASSEMBLY

06/01/2026referred to health

Go to topS04640 Committee&nbspVotes:

Go to topS04640 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS04640 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4640--A

 2025-2026 Regular Sessions

 IN SENATE

 February 10, 2025
 ___________

 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
 printed to be committed to the Committee on Alcoholism and Substance
 Use Disorders -- committee discharged, bill amended, ordered reprinted
 as amended and recommitted to said committee

 AN ACT to amend the public health law, in relation to onsite overdose
 response services and requiring certain locations and venues to main-
 tain a supply of opioid antagonists

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subdivisions 1, 3, 4 and 8 of section 3309 of the public
 2 health law, subdivisions 1 and 3 as amended by chapter 42 of the laws of
 3 2014, subparagraph (iv) of paragraph (a) of subdivision 3 and subdivi-
 4 sion 4 as amended and subparagraph (v) of paragraph (a) of subdivision 3
 5 as added by chapter 148 of the laws of 2020, subparagraph (vi) of para-
 6 graph (a) of subdivision 3 and subdivision 8 as added by chapter 83 of
 7 the laws of 2023, and subparagraph (v) of paragraph (b) of subdivision 3
 8 as added by chapter 65 of the laws of 2016, are amended to read as
 9 follows:
 10 1. The commissioner is authorized to establish standards for approval
 11 of any opioid overdose prevention program, onsite overdose response
 12 services, and opioid antagonist prescribing, dispensing, distribution,
 13 possession and administration pursuant to this section which may
 14 include, but not be limited to, standards for program directors, appro-
 15 priate clinical oversight, training, record keeping and reporting.
 16 3. (a) As used in this section:
 17 (i) "Opioid antagonist" means a drug approved by the Food and Drug
 18 Administration that, when administered, negates or neutralizes in whole
 19 or in part the pharmacological effects of an opioid in the body. "Opioid
 20 antagonist" shall be limited to naloxone and other medications approved
 21 by the department for such purpose.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD08571-02-5

 S. 4640--A 2

 1 (ii) "Health care professional" means a person licensed, registered or
 2 authorized pursuant to title eight of the education law to prescribe
 3 prescription drugs.
 4 (iii) "Pharmacist" means a person licensed or authorized to practice
 5 pharmacy pursuant to article one hundred thirty-seven of the education
 6 law.
 7 (iv) "Opioid antagonist recipient" [or "recipient"] means a person at
 8 risk of experiencing an opioid-related overdose, or a family member,
 9 friend or other person in a position to assist a person experiencing or
 10 at risk of experiencing an opioid-related overdose, or an organization
 11 registered as an opioid overdose prevention program pu